Quick Answer
TREACE MEDICAL CONCEPTS, INC. reported R&D Expense of $20.28 million for fiscal year 2025.
TREACE MEDICAL CONCEPTS, INC. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $20.28M | -1.5% |
| 2024 | $20.59M | +33.3% |
| 2023 | $15.44M | +13.7% |
| 2022 | $13.58M | +33.1% |
| 2021 | $10.20M | +74.5% |
| 2020 | $5.85M | +15.3% |
| 2019 | $5.07M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.68M | -5.7% | -14.9% |
| June 30, 2025 | $5.50M | +6.6% | -1.2% |
| March 31, 2025 | $5.56M | +5.8% | +12.1% |
| September 30, 2024 | $4.96M | +14.1% | -3.8% |
| June 30, 2024 | $5.16M | +46.3% | -1.9% |
| March 31, 2024 | $5.26M | +54.1% | +20.9% |
| September 30, 2023 | $4.35M | +14.5% | +23.4% |
| June 30, 2023 | $3.53M | +18.2% | +3.3% |
- TREACE MEDICAL CONCEPTS, INC. showed a decrease of -1.5% in R&D Expense compared to the prior fiscal year.
- Over the 2019–2025 period, TREACE MEDICAL CONCEPTS, INC.’s r&d expense has grown by 300.0% (from $5.07 million to $20.28 million).
- The most recent figure is from TREACE MEDICAL CONCEPTS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: